Navigation Links
New superbug surpasses MRSA infection rates in community hospitals
Date:3/22/2010

ATLANTA, GA While prevention methods appear to be helping to lower hospital infection rates from MRSA, a deadly antibiotic-resistant bacterium, a new superbug is on the rise, according to research from the Duke Infection Control Outreach Network.

New data shows infections from Clostridium difficile are surpassing methicillin-resistant Staphylococcus aureus (MRSA) infections in community hospitals.

"We found that MRSA infections have declined steadily since 2005, but C. difficile infections have increased since 2007," said Becky Miller, M.D., an infectious diseases fellow at Duke University Medical Center.

C. difficile is a multi-drug resistant bacterium that causes diarrhea and in some cases life-threatening inflammation of the colon. The infections are currently treated with one of two antibiotics. But relapses are common and occur in one-quarter of patients despite treatment, according to Miller.

"This is not a nuisance disease," said Daniel Sexton, M.D., director of the Duke Infection Control Outreach Network (DICON). "A small percentage of patients with C. difficile may die, despite treatment. Also, it is likely that the routine use of alcohol-containing hand cleansers to prevent infections from MRSA does not simultaneously prevent infections due to C difficile."

Miller and her team evaluated data from 28 hospitals in DICON, a collaboration between Duke and 39 community hospitals located in Georgia, North Carolina, South Carolina and Virginia. The group tries to improve infection control programs by compiling data on infections occurring at member hospitals, identifying trends and areas for improvement, and providing ongoing education and leadership to community providers.

During a 24-month period, there were 847 cases of C. difficile infections in the 28 hospitals and the rate of C. difficile infection was 25 percent higher than the rate of infection due to MRSA.

Miller presented her findings at the Fifth Decennial International Conference on Healthcare-Associated Infections on March 20 in Atlanta, GA.

"C. difficile is very common and deserves more attention," she said. "Most people continue to think of MRSA as the big, bad superbug. Based on our data, we can see that this thinking, along with prevention methods, will need to change."

In the past, hospitals were focused on MRSA and developed their prevention methods on MRSA as the issue, Sexton said.

"I have always thought that we need to be looking more globally at all the problems and this new information about C. difficile provides more data to support that," he said.

C. difficile has been a low priority for hospitals, but now it is relatively important priority, Sexton said.

"The key is to develop prevention methods aimed at C. difficile while still maintaining the success we have had with MRSA," Miller said.


'/>"/>

Contact: Erin Pratt
erin.pratt@duke.edu
919-660-1317
Duke University Medical Center
Source:Eurekalert

Related medicine news :

1. No Sign of Superbugs in Isolated Polar Bears
2. Giant Eagle Pharmacy Free Antibiotics Program Surpasses $3 Million in Free Prescriptions
3. Studies Show Significant Increases of C. Difficile Infections (CDI)
4. Targeting blood vessels, immune system may offer way to stop infection-caused inflammation
5. Study says therapeutics for trauma patients may not be effective due to an infection
6. Flexible Floor-Cleaning Routine Helps School Prevent Spread of Infection
7. University of Michigan scientists identify chemical in bananas as potent inhibitor of HIV infection
8. Heat Therapy Helps Treat U.S. Soldiers Infections
9. 24x7 Infection Control, Inc. Announces World's First, Modern “Shield” Against Microbial Contamination
10. Scientific community to set research agenda for infection prevention and control for next decade
11. MSU researcher links potentially deadly infection, frequent cow exposure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... boca raton florida (PRWEB) , ... January 20, 2017 , ... ... trial at the Dana Farber Cancer Institute. For Betsy, the clinical trial has ... and her cancer has not worsened. , Betsy Brauser was diagnosed with ovarian ...
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... “Mary Magdalene: ... the mysterious life of the woman who witnessed Jesus Christ firsthand. “Mary Magdalene: Grace ... denizen, who spent her career as an educator interacting with countless women who had ...
(Date:1/20/2017)... ... ... “I Forgive You”: a fine examination of how God handles sin, including how to ... author, Stephen Miller, who, for over ten long years has been waiting to release this ... and Tobago, he has been serving the Lord for over twenty years, and he has ...
(Date:1/20/2017)... ... 20, 2017 , ... “Journey to Christmas:” a beautiful and enchanting tale that teaches children the ... a mother of three in Oklahoma City, and a devoted woman of faith. , ... has been in the back of my mind for years, but actually doing it might ...
(Date:1/20/2017)... ... , ... “God's Miracle Man: Against All Odds”: an inspiring affirmation of ... Keith C. A. Tucker, son of Minister Delores Pinnock and a Jamaican native who ... Hardy , “While sitting up in bed, I felt a pounding headache. It was ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 19, 2017 Incretin Mimetics/GLP-1 Agonists, SNDRIs, Lipase ... The global anti-obesity drugs market is expected to ... the forecast period and CAGR of 38.7% in the second half ... a CAGR of 32.8% from 2016 to 2027. The market is ... $24,063 million in 2027. ...
(Date:1/19/2017)... , Jan. 19, 2017 Accuray Incorporated (Nasdaq: ... and TomoTherapy® Systems continue to set the bar for ... highest composite overall user satisfaction rating among radiation treatment ... 2016 MD Buyline Market Intelligence Briefing™. The most recent ... composite ratings among industry peers for 11 of the ...
(Date:1/19/2017)... , January 19, 2017 ... European Oncology & Haematology, 2016;12(Suppl 2):3-8; http://www.touchoncology.com/articles/optimising-clinical-outcomes-gastrointestinal-cancers-through-inhibiting-angiogenesis-and ... ... Published recently in a supplement ... journal from touchONCOLOGY, an article by James ...
Breaking Medicine Technology: